Search

everythinglearnresearchcommunity

for

Search:↓

Microneedles with green tea polyphenols improve diabetic wound healing.

Enzyme booster SULT1A1 greatly enhances hair regrowth with minoxidil.

SeV-Tp speeds up healing of drug-resistant infections by targeting wounds and killing bacteria with light activation.

Higher monocyte counts predict less effective adalimumab treatment in hidradenitis suppurativa patients.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Social media influencers often promote self-medication, which can be dangerous without professional guidance.

A new 3D breast tumor model helps test drug effects more accurately than traditional methods.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

Laser treatment, especially when combined with other therapies, is effective for hair regrowth in alopecia areata.

Alkylated keratin from human hair can help deliver growth factors for bone healing.

A hair test can accurately predict if a person with hair loss will respond to minoxidil treatment.

3D cultures respond better to minoxidil, while 2D cultures respond better to DHT.

Cepharanthine could be a strong antiviral against COVID-19.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Hair analysis can detect cocaine use but doesn't accurately show the amount or timing of use.

Topical Vorinostat shows promise for treating alopecia areata by promoting hair regrowth.

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.

Most pediatric cancer patients at Muhimbili National Hospital experienced adverse drug reactions during chemotherapy, highlighting the need for careful monitoring.

Key proteins and potential drugs for treating alopecia areata were identified.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

Androgen receptors help prostate cancer cells grow and resist drugs.

Organoid technology is improving personalized medicine by better predicting drug responses and treatments.

The model can effectively test gene functions and drug responses in human skin.

Tight junctions are key for skin protection and controlling what gets absorbed or passes through the skin.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

The skin is the largest organ, protecting the body, regulating temperature, and producing hormones.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.